Cost-effectiveness model
lung cancer
LUNG CANCER
To address the 7th objective, the cost-effectiveness of lung cancer screening based on the developed models will be evaluated. The SiMRiSc simulation model will be applied [In the cost-effectiveness model, one-way sensitivity analyses will be carried out to explore parameter uncertainty of the most cost-effective scenario at the assumed threshold per life year gained. The baseline values of the input parameters will be varied by an increase and decrease of two standard deviations for the base case analysis.